BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

269 related articles for article (PubMed ID: 23268317)

  • 1. Adenocarcinoma of gallbladder: an immunohistochemical profile and comparison with cholangiocarcinoma.
    Hughes NR; Bhathal PS
    J Clin Pathol; 2013 Mar; 66(3):212-7. PubMed ID: 23268317
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Liver fluke-associated and sporadic cholangiocarcinoma: an immunohistochemical study of bile duct, peribiliary gland and tumour cell phenotypes.
    Hughes NR; Pairojkul C; Royce SG; Clouston A; Bhathal PS
    J Clin Pathol; 2006 Oct; 59(10):1073-8. PubMed ID: 16679351
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The expression of matrix metalloproteinases in intrahepatic cholangiocarcinoma, hilar (Klatskin tumor), middle and distal extrahepatic cholangiocarcinoma, gallbladder cancer, and ampullary carcinoma: role of matrix metalloproteinases in tumor progression and prognosis.
    Kirimlioğlu H; Türkmen I; Başsüllü N; Dirican A; Karadağ N; Kirimlioğlu V
    Turk J Gastroenterol; 2009 Mar; 20(1):41-7. PubMed ID: 19330734
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cell adhesion molecules P-cadherin and CD24 are markers for carcinoma and dysplasia in the biliary tract.
    Riener MO; Vogetseder A; Pestalozzi BC; Clavien PA; Probst-Hensch N; Kristiansen G; Jochum W
    Hum Pathol; 2010 Nov; 41(11):1558-65. PubMed ID: 20621328
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Intracholecystic papillary-tubular neoplasms (ICPN) of the gallbladder (neoplastic polyps, adenomas, and papillary neoplasms that are ≥1.0 cm): clinicopathologic and immunohistochemical analysis of 123 cases.
    Adsay V; Jang KT; Roa JC; Dursun N; Ohike N; Bagci P; Basturk O; Bandyopadhyay S; Cheng JD; Sarmiento JM; Escalona OT; Goodman M; Kong SY; Terry P
    Am J Surg Pathol; 2012 Sep; 36(9):1279-301. PubMed ID: 22895264
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prevalence and risk factors for gallbladder neoplasia in patients with primary sclerosing cholangitis: evidence for a metaplasia-dysplasia-carcinoma sequence.
    Lewis JT; Talwalkar JA; Rosen CB; Smyrk TC; Abraham SC
    Am J Surg Pathol; 2007 Jun; 31(6):907-13. PubMed ID: 17527079
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Expression of p53 in gallbladder carcinoma and in dysplastic and metaplastic lesions of the surrounding mucosa].
    Billo P; Marchegiani C; Capella C; Sessa F
    Pathologica; 2000 Aug; 92(4):249-56. PubMed ID: 11029885
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Adenomas of the gallbladder. Morphologic features, expression of gastric and intestinal mucins, and incidence of high-grade dysplasia/carcinoma in situ and invasive carcinoma.
    Albores-Saavedra J; Chablé-Montero F; González-Romo MA; Ramírez Jaramillo M; Henson DE
    Hum Pathol; 2012 Sep; 43(9):1506-13. PubMed ID: 22386521
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pyloric gland metaplasia with perineural invasion of the gallbladder: A lesion that can be confused with adenocarcinoma.
    Albores-Saavedra J; Henson DE
    Cancer; 1999 Dec; 86(12):2625-31. PubMed ID: 10594857
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Co-expression of gastric and biliary phenotype in pyloric-gland type adenoma of the gallbladder: immunohistochemical analysis of mucin profile and CD10.
    Nagata S; Ajioka Y; Nishikura K; Watanabe G; Inoue T; Yamaguchi K; Watanabe H; Tanaka M; Tsuneyoshi M
    Oncol Rep; 2007 Apr; 17(4):721-9. PubMed ID: 17342306
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Histogenesis of gallbladder cancer with special reference to metaplastic changes and distribution of various mucins and CEA].
    Inada A; Konishi F; Yamamichi N; Ito H
    Nihon Geka Gakkai Zasshi; 1989 Jun; 90(6):894-906. PubMed ID: 2796960
    [TBL] [Abstract][Full Text] [Related]  

  • 12. An immunohistochemical profile of the so-called bile duct adenoma: clues to pathogenesis.
    Hughes NR; Goodman ZD; Bhathal PS
    Am J Surg Pathol; 2010 Sep; 34(9):1312-8. PubMed ID: 20679879
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Reduced p21(WAF1/CIP1) expression is an early event in gallbladder carcinogenesis and is of prognostic significance for patients with carcinomas of the gallbladder.
    Li X; Hui AM; Shi YZ; Takayama T; Makuuchi M
    Hum Pathol; 2001 Aug; 32(8):771-7. PubMed ID: 11521218
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Chronic Inflammatory and Proliferative Lesions of the Gallbladder in Aged Pigs.
    Ushio N; Chambers JK; Watanabe KI; Kishimoto TE; Shiga T; Li JY; Nakayama H; Uchida K
    Vet Pathol; 2020 Jan; 57(1):122-131. PubMed ID: 31551021
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Neoplasms and dysplasias of the gallbladder and their relationship with lithiasis. A case-control clinicopathological study].
    Martínez-Guzmán G; de la Rosa-Bayón J
    Rev Gastroenterol Mex; 1998; 63(2):82-8. PubMed ID: 10068733
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Expressive levels of MUC1 and MUC5AC and their clinicopathologic significances in the benign and malignant lesions of gallbladder.
    Xiong L; Yang Z; Yang L; Liu J; Miao X
    J Surg Oncol; 2012 Jan; 105(1):97-103. PubMed ID: 21815153
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pyloric gland adenoma: a histologic, immunohistochemical and molecular genetic study of 23 cases.
    Chlumská A; Waloschek T; Mukenšnabl P; Martínek P; Kašpírková J; Zámečník M
    Cesk Patol; 2015; 51(3):137-43. PubMed ID: 26421956
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Preneoplastic lesions in gallbladder cancer.
    Roa I; de Aretxabala X; Araya JC; Roa J
    J Surg Oncol; 2006 Jun; 93(8):615-23. PubMed ID: 16724345
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Endocrine cells and lysozyme immunoreactivity in the gallbladder.
    Yamamoto M; Nakajo S; Tahara E
    Arch Pathol Lab Med; 1986 Oct; 110(10):920-7. PubMed ID: 2429636
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Immunohistochemical analysis of morules in colonic neoplasms: morules are morphologically and qualitatively different from squamous metaplasia.
    Ueo T; Kashima K; Daa T; Kondo Y; Sasaki A; Yokoyama S
    Pathobiology; 2005; 72(5):269-78. PubMed ID: 16374071
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.